Interplay of metabolizing enzymes and transporter of xenobiotics

References

• Allen JD, van Loevezijn A, Lakhai JM, et al. (2002). Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther 1:417–25
   PubMed Web of Science ®Google Scholar
• Chearwae W, Shukla S, Limtrakul P, Ambudkar SV. (2006). Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol Cancer Ther 5:1995–2006
   PubMed Web of Science ®Google Scholar
• Ciaccio PJ, Tew KD, LaCreta FP. (1990). The spontaneous and glutathione S-transferase-mediated reaction of chlorambucil with glutathione. Cancer Commun 2:279–85
   PubMed Web of Science ®Google Scholar
• Clayton TA, Baker D, Lindon JC, et al. (2009). Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Nat Acad Sci USA 106:14728–33
   PubMed Web of Science ®Google Scholar
• Cook JA, Iype SN, Mitchell JB. (1991). Differential specificity of monochlorobimane for isozymes of human and rodent glutathione S-transferases. Cancer Res 51:1606–12
   PubMed Web of Science ®Google Scholar
• Enokizono J, Kusuhara H, Sugiyama Y. (2007). Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 72:967–75
   PubMed Web of Science ®Google Scholar
• Feigenbaum J, Neuberg CA. (1941). Simplified method for the preparation of aromatic sulfuric acid esters. J Am Chem Soc 63:3529–30
   Google Scholar
• Giacomini KM, Huang SM, Tweedie DJ, et al. (2010). Membrane transporters in drug development. Nat Rev Drug Discov 9:215–36
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Fojo T, Bates SE. (2002). Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48–58
   PubMed Web of Science ®Google Scholar
• Hall A, Robson CN, Hickson ID, et al. (1989). Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line. Cancer Res 49:6265–8
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Hewitt P. (2004). Phase I and II enzyme characterization of two sources of HepG2 cell lines. Xenobiotica 34:243–56
   PubMed Web of Science ®Google Scholar
• Huang CS, Chang LS, Anderson ME, Meister A. (1993). Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J Biol Chem 268:19675–80
   PubMed Web of Science ®Google Scholar
• Huls M, Brown CD, Windass AS, et al. (2008). The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 73:220–5
   PubMed Web of Science ®Google Scholar
• Imai Y, Asada S, Tsukahara S, et al. (2003). Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol Pharmacol 64:610–18
   PubMed Web of Science ®Google Scholar
• Imai Y, Tsukahara S, Asada S, Sugimoto Y. (2004). Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 64:4346–52
   PubMed Web of Science ®Google Scholar
• Ireson CR, Jones DJ, Orr S, et al. (2002). Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11:105–11
   PubMed Web of Science ®Google Scholar
• Kruijtzer CM, Beijnen JH, Rosing H, et al. (2002). Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. J Clin Oncol 20:2943–50
   PubMed Web of Science ®Google Scholar
• Lim HW, Lim HY, Wong KP. (2009). Uncoupling of oxidative phosphorylation by curcumin: implication of its cellular mechanism of action. Biochem Biophys Res Commun 389:187–92
   PubMed Web of Science ®Google Scholar
• Limtrakul P, Chearwae W, Shukla S, et al. (2007). Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol Cell Biochem 296:85–95
   PubMed Web of Science ®Google Scholar
• Martinez AW, Recht NS, Hostetter TH, Meyer TW. (2005). Removal of P-cresol sulfate by hemodialysis. J Am Soc Nephrol 16:3430–6
   PubMed Web of Science ®Google Scholar
• Mulder GJ, Scholtens E. (1977). Phenol sulphotransferase and uridine diphosphate glucuronyltransferase from rat liver in vivo and vitro. 2,6-Dichloro-4-nitrophenol as selective inhibitor of sulphation. Biochem J 165:553–9
   Google Scholar
• Ng KH, Lim BG, Wong KP. (2003). Sulfate conjugating and transport functions of MDCK distal tubular cells. Kidney Int 63:976–86
   PubMed Web of Science ®Google Scholar
• Nickel S, Mahringer A. (2014). The xenoestrogens ethinylestradiol and bisphenol A regulate BCRP at the blood–brain barrier of rats. Xenobiotica 44:1046–54
   PubMed Web of Science ®Google Scholar
• Smith PK, Krohn RI, Hermanson GT, et al. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85
   PubMed Web of Science ®Google Scholar
• Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y. (2003). ABCG2 transports sulfated conjugates of steroids and xenobiotics. J Biol Chem 278:22644–9
   PubMed Web of Science ®Google Scholar
• Ublacker GA, Johnson JA, Siegel FL, Mulcahy RT. (1991). Influence of glutathione S-transferases on cellular glutathione determination by flow cytometry using monochlorobimane. Cancer Res 51:1783–8
   PubMed Web of Science ®Google Scholar
• Vietri M, De Santi C, Pietrabissa A, et al. (2000). Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs. Eur J Clin Pharmacol 56:81–7
   PubMed Web of Science ®Google Scholar
• Wong KP. (1982). Sulphate conjugation of amines and their metabolites. In: Mulder GJ, Caldwell J, Van Kempen GMJ, Vonk RJ, eds. Sulfate metabolism and sulfate conjugation. London: Taylor & Francis
   Google Scholar
• Zamek-Gliszczynski MJ, Day JS, Hillgren KM, Phillips DL. (2011). Efflux transport is an important determinant of ethinylestradiol glucuronide and ethinylestradiol sulfate pharmacokinetics. Drug Metab Dispos 39:1794–800
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Hoffmaster KA, Humphreys JE, et al. (2006a). Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat. J Pharmacol Exp Ther 319:459–67
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Hoffmaster KA, Nezasa K, Brouwer KL. (2008). Apparent differences in mechanisms of harmol sulfate biliary excretion in mice and rats. Drug Metab Dispos 36:2156–8
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Hoffmaster KA, Nezasa K, et al. (2006b). Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci 27:447–86
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Hoffmaster KA, Tweedie DJ, et al. (2012). Highlights from the International Transporter Consortium second workshop. Clin Pharmacol Ther 92:553–6
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Nezasa K, Tian X, et al. (2006c). The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice. Mol Pharmacol 70:2127–33
   PubMed Web of Science ®Google Scholar
• Zhang K, Wong KP. (1996). Inhibition of the efflux of glutathione S-conjugates by plant polyphenols. Biochem Pharmacol 52:1631–8
   PubMed Web of Science ®Google Scholar